The Abbott Laboratories (ABT) revenue growth is 3.1%, which is lower than the industry median of 15.0% and the 5-year historical average of 6.3%.
The Abbott Laboratories (ABT) operating income growth is 7.5%, compared to the industry median of (3.3%) and the 5-year historical average of 16.6%.
The Abbott Laboratories (ABT) EPS growth is 12.1%, compared to the industry median of (19.7%) and the 5-year historical average of 22.1%.
The Abbott Laboratories (ABT) Free Cash Flow growth is 44.4%, compared to the industry median of (13.4%) and the 5-year historical average of 11.9%.